ODYSSEUS
ODYSSEUS
RegistradaNominativa · Brasil
Outros setoresTecnologiaEducaçãoSoftware e TI
Andamento no INPI
- Depósito31/01/25
- Publicação05/08/25
- Exame
- Deferimento02/06/26
- Concessão
- Vigente31/01/35
Registro concedido e em vigor até 31/01/2035, quando precisa ser renovado.
Proteção válida até:31/01/2035
Vigiar esta marcaÚltima movimentação publicada pelo INPI: 16/06/2026 (RPI 2893). Atualizamos a cada nova RPI, publicada semanalmente.
Marca registrada: vale avaliar o risco de conflito
A marca "ODYSSEUS" está registrada no Brasil. Se você usa ou pretende usar um nome similar, pode haver risco de conflito. Vale olhar classes, histórico e despachos antes de decidir o próximo passo.
Panorama da marca
- Situação INPI
- Registro de marca em vigor (Madri)
- Idade do processo
- 1 ano e 8 meses
- Eventos no processo
- 4
- Última atualização
- 16 de junho de 2026
Dados do processo
- Titular
- Trogenix Ltd
- Número do processo
- 501851447
- Número de registro
- 501851447
- Natureza
- Madri Produto/Serviço
- Data do depósito
- 31 de janeiro de 2025
- Válido até
- 31 de janeiro de 2035
Produtos e serviços cobertos
Pharmaceutical, medical or veterinary preparations and substancesRNA therapeuticspharmaceutical preparations for use in targeted pharmaceutical therapiespharmaceutical preparations and products for the treatment of neoplastic diseasespharmaceutical preparations and products for the treatment of carcinomas and leukaemiaspharmaceutical preparations and products for the treatment of central nervous system tumours, glioblastoma, colorectal liver metastasis, squamous cell carcinomas, pancreatic cancer, melanoma, breast cancer, sarcomas, paediatric solid tumours, hepatocellular carcinoma, cancer of the eye and metastatic tumoursenhancers or super-enhancers for medical or clinical usepromoters for medical usesynthetic super enhancers in gene expression cassettes for medical or clinical useDNA sequences and RNA sequences for medical purposestransgenes for medical purposespharmaceutical preparations for use in regenerative medicines for treatment of fibrosis, age-associated disorders, senescence, rejuvenation, neurological disease, tissue injury and tissue repairgene therapy pharmaceuticalspharmaceutical preparations being vectorsbiotechnological preparations for medical usebiological compounds for use in the targeted pharmaceutical therapiesproteins with diagnostic and therapeutic useschemical and enzyme preparations for medical or veterinary purposesreagents and substances for use in testing for medical and veterinary purposesdrug delivery agents that facilitate the delivery of pharmaceutical preparationsclinical medical reagentsdiagnostic and testing preparations for clinical, medical and medical laboratory usepharmaceuticals in the field of modulating therapeuticspharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, otologic, respiratory, neurological, gastrointestinal, pancreatic, nephrologic, musculoskeletal, hormonal, dermatological, psychiatric and immune system related diseases and disordersbiological preparations for the treatment of cancerbiological preparations for use in cell cultures for medical purposesdiagnostic biomarker reagents for medical purposescells for medical or clinical useimmune cellstarget antigens for medical usevaccine preparationstherapeutic vaccines
Downloadable computer software programsdownloadable software, namely, lab information management systemscomputer software platformsdownloadable software for remote diagnosticsmachine learning softwaremachine learning software for use in genetic sequencingalgorithms, being computer softwarebioinformatics softwareimaging apparatus and instruments for use in the study of proteins and peptides in drug developmentdata processing softwaredownloadable computer applications in the fields of oncology, regenerative medicine, immunotherapy, recombinant protein production, immunology, cell engineering, CAR-T, viral vector engineering, genetic engineering, biopharmaceuticals, molecular biology, modulating therapeutics, assay systems, antigens and in vitro assayssoftware for predicting protein expressionsoftware in the fields of genomes, genetic mapping, molecular genetics, gene regulation, molecular biology, microbiology, pharmaceuticals, medicine, diagnostic preparations, vaccines, medicine, health, microorganisms, molecular sciences, bacteria, biochemicals, cells, stem cells, organoids, cancer stem cells, clinical trials, physiology, genetics, genomics, microbiome, metabolomics, metagenomics, proteomics, glycomics, biochemistry, therapeutics, targeted pharmaceutical therapies, bacteriology, gene expression, DNA sequencing, DNA screening, RNA sequencing, RNA screening, transgenes, biochemical reagents and biochemical assaysdownloadable computer software for scientific analysis of genetic sequencessoftware algorithms in the fields of biotechnology and modulating therapeuticssoftware as a medical deviceartificial intelligence software in the field of healthcare
Educação religiosa
Design, development and maintenance of software in the fields of genetic sequencing, genomes, genetic mapping, molecular genetics, gene regulation, molecular biology, synthetic biology, engineering biology, DNA assembly, DNA synthesis, genome editing, protein engineering, antibody engineering, microbiology, pharmaceuticals, medicine, diagnostic preparations, immunopharmaceuticals, vaccines, medicine, health, microorganisms, molecular sciences, bacteria, biochemicals, cells, stem cells, organoids, cancer stem cells, clinical trials, physiology, genetics, genomics, microbiome, metabolomics, metagenomics, proteomics, glycomics, biochemistry, therapeutics, targeted pharmaceutical therapies, bacteriology, gene expression, DNA sequencing, DNA screening, RNA sequencing, RNA screening, transgenes, biochemical reagents and biochemical assaysdesign, development and maintenance of software algorithms in the fields of biotechnology and modulating therapeuticsdesign, development and maintenance of software in the fields of oncology, regenerative medicine, immunotherapy, recombinant protein production, immunology, cell engineering, CAR-T, viral vector engineering, genetic engineering, biopharmaceuticals, molecular biology, modulating therapeutics, assay systems, antigens and in vitro assaysdesign, development and maintenance of machine learning software for use in bioinformatics, genetic sequencing, predicting protein expression, cell suppression and analysis of cell behavioursgene regulation control servicesgene regulatory network analysisanalysis, management and review of technical datadevelopment and testing of computing methods, algorithms and softwaredesign, development and maintenance of machine learning softwareresearch in the field of artificial intelligence softwaredesign and development of lab information management systemsdesign and development of software testing methodsproviding non-downloadable software for controlling, monitoring, programming and adjusting environmental conditions for cell culture, cell therapy or gene therapysoftware as a service [SaaS] platforms and tools for collecting and interpreting clinical dataplatform as a service servicescomputer aided analysis services in the field of pharmaceuticalsdatabase development and maintenance servicesdesign and development of computer platformsresearch and development services in the fields of pharmacogenetics, targeted pharmaceutical therapies and drug delivery platformsresearch and development services in the field of regenerative medicines for the treatment of fibrosis, age-associated disorders, senescence, rejuvenation, neurological disease, tissue injury and tissue repairresearch and development services in the fields of pharmaceuticals, immunopharmaceuticals, neoplastic diseases, modulating therapeutics, enhancers, super-enhancers, promoters, synthetic super enhancers in gene expression, DNA sequences, RNA sequences, fluorescent reporters, genetic cassettes, transgenes, gene therapy, drug delivery agents, vectors, diagnostic biomarker reagents, cell cultures, cell engineering, immunology and vaccinesresearch and development services in the fields of synthetic biology, engineering biology, DNA assembly, DNA synthesis, genome editing, protein engineering and antibody engineeringresearch and development services for the treatment of cancers, carcinomas, leukaemias, central nervous system tumours, glioblastoma, colorectal liver metastasis, squamous cell carcinomas, pancreatic cancer, melanoma, breast cancer, sarcomas, paediatric solid tumours, hepatocellular carcinoma, cancer of the eye and metastatic tumoursresearch and development services for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, otologic, respiratory, neurological, gastrointestinal, pancreatic, nephrologic, musculoskeletal, hormonal, dermatological, psychiatric and immune system related diseases and disordersbiological, biochemical, biomedical, bacteriological and pharmacological research, analysis, engineering and development servicesbiological laboratory servicescell engineering services, namely cell suppression, cell activation, and cell programming and reprogrammingculturing of cells for scientific or medical research purposescontract research services relating to enhancers, and super-enhancers and promotersdrug development servicesdevelopment of gene-based medicinesproviding information about medical research in the fields of biopharmaceuticals, immunology, cell engineering and immunoassaysscientific services relating to the isolation and cultivation of human tissues and cellslaboratory services namely, research, analysis, characterising, development and production of therapeutics for the treatment of neoplastic diseases, carcinomas, leukaemias, central nervous system tumours, glioblastoma, colorectal liver metastasis, squamous cell carcinomas, pancreatic cancer, melanoma, breast cancer, sarcomas, paediatric solid tumours, hepatocellular carcinoma, cancer of the eye and metastatic tumoursgenetic engineering servicesgenetic sequencing and genotyping servicesRNA sequencing servicesanalysis services regarding the safety and efficacy of new pharmaceuticalsdiagnostic services in the field of immunologypolymerase chain reaction [PCR] servicespreparation of reports in the field of biotechnologytesting of human tissues and stem cells for scientific or medical research purposesuse of biomarkers to investigate human immune response for medical purposesdesign, research, analysis and engineering services relating to genetic cassettesdesign and engineering services relating to genomic safe harbours, recombination sites, minimal promoters, insulators, splicing control elements, gene terminators, UTRs, capsids, fusion linkers, translational control elements and transcriptional unitsRNA sequence optimisation servicesevaluation services relating to RNA qualitytranslational control services in the field of gene expressiondesign of therapeutic payloadsconsultancy, information and advisory services relating to all of the aforesaid services
Linha do tempo do processo
4 eventosMovimentações mais recentes da marca “ODYSSEUS” publicadas na Revista da Propriedade Industrial (RPI). O detalhe de cada despacho fica na consulta completa.
- Concessão / deferimento16 de jun. de 2026RPI 2893
Concessão de registro em designação
Detalhes na consulta completa - Andamento05 de mai. de 2026RPI 2887
Anotação de alteração de nome e/ou endereço em designação
Detalhes na consulta completa
Saiba mais (+1 movimentação)
Veja o histórico completo de despachos desta marca e receba alertas de novas movimentações.
Ver histórico completoO que fazer se a sua marca se aproxima de "ODYSSEUS"?
Conflitos de marcas no Brasil são resolvidos com base na anterioridade do depósito, nas classes de Nice e no segmento de atuação. O processo tem várias fases e pode ficar complexo quando o nome é parecido ou o mercado se cruza. Uma leitura cuidadosa ajuda a decidir se vale seguir, ajustar ou recuar.
A TrademarkIQ cruza histórico, decisões e padrões de aprovação por classe e setor em uma base com +6 milhões de processos brasileiros. Isso ajuda a enxergar o risco com mais contexto e a encontrar o melhor caminho comercial e jurídico para a sua marca.
Marcas semelhantes
Outros processos no INPI com nome próximo de "ODYSSEUS".
Outras marcas do titular
Processos de marca no INPI em nome de Trogenix Ltd.
Escritórios especializados
Lancaster Marcas e Patentes
84% aprovação
Potenza Brasil
David do Nascimento Propriedade Intelectual
83% aprovação
Quer registrar a sua marca?
- 1Diga o nome e o ramo. A análise de anterioridade sai da base oficial do INPI, a mesma que você acabou de consultar.
- 2Um escritório verificado assume o caso, define as classes e a especificação, e protocola no INPI.
- 3Você recebe o número do processo e acompanha cada despacho até a decisão final.
Sem custo para pedir a análise. O preço depende do escritório e do caso.
Dados atualizados a partir de uma base com +6 milhões de marcas brasileiras analisadas. Esta página é informativa e não substitui parecer jurídico, mas ajuda a orientar a decisão com mais contexto comercial e técnico.